- Drugs (psychoactive) - World Health Organization (WHO)
The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important
- Alcohol, Drugs and Addictive Behaviours
Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours
- WHO Drug Information
About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
- Drugs (psychoactive) - World Health Organization (WHO)
Substitution maintenance therapy with methadone or buprenorphine improves the health and social performance of opioid-dependent people and decreases the use of illicit drugs and the crime rate Statistics show that investment in prevention pays off well: every dollar invested in drug treatment saves seven dollars in health and social costs
- WHO Model Lists of Essential Medicines
The WHO Model Lists of Essential Medicines are updated every two years by the Expert Committee on Selection and Use of Essential Medicines The first Essential Medicines List was published in 1977, and the first Essential Medicines List for Children was published in 2007 The current versions, updated in July 2023, are the 23 rd Essential Medicines List (EML) and the 9 th Essential Medicines
- WHO updates guidelines on opioid dependence treatment and overdose . . .
WHO announces development of updated guidelines for the psychosocially assisted pharmacological treatment of opioid dependence and community management of opioid overdoseIn 2022, approximately 60 million people globally engaged in non-medical opioid use, including the use of drugs like heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances Their regular non
- Guidelines for HIV post-exposure prophylaxis
WHO’s updated PEP guidelines prioritize broader access to PEP, including community-based delivery and task sharing to mitigate barriers such as stigma and to ensure timely access post exposure PEP involves administering antiretroviral (ARV) medication after potential HIV exposure to prevent infection
- UN Commission approves WHO recommendations to place psychoactive . . .
Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under international control
|